A nurse is caring for a newborn who is small for gestational age (SGA). Which nursing intervention should be the priority?

An infant is classified as small for gestational age (SGA) when their birth weight falls below the 10th percentile for their gestational age. This condition indicates intrauterine growth restriction (IUGR) or constitutional smallness, which fundamentally means the newborn has depleted glycogen stores, reduced adipose tissue, and immature metabolic regulatory systems. Because these infants have limited energy reserves and high metabolic demands, they are at a significantly elevated risk for neonatal complications, particularly metabolic disturbances in the immediate postnatal period.

The priority intervention for an SGA newborn is to monitor blood glucose levels and provide frequent feedings. The transition from intrauterine to extrauterine life requires a successful metabolic adaptation where the newborn must mobilize glucose independently after the placental supply is cut. In SGA infants, this process is compromised. A systematic review of international clinical guidelines identifies neonatal hypoglycemia as one of the most common metabolic disturbances in the first 24-72 hours of life ^[2]. Due to their depleted glycogen stores, SGA neonates are a primary at-risk group. If hypoglycemia is not promptly recognized and treated, it can lead to acute neurological complications and long-term neurodevelopmental impairment ^[4].

Frequent feedings, ideally with breast milk, directly counteract this risk by providing an exogenous glucose source. A narrative review on SGA neonates highlights that breastfeeding is a critical factor in promoting healthier growth and long-term metabolic health, although these infants are at risk of growth failure ^[1]. The act of feeding stimulates gut hormones and promotes gluconeogenesis, stabilizing blood glucose more effectively than simply waiting for endogenous regulation. Monitoring blood glucose before feedings allows the nurse to detect asymptomatic hypoglycemia early, which is crucial because a prospective cohort study demonstrates that reliable early biomarkers to estimate hypoglycemia risk are often lacking, making vigilant clinical surveillance essential ^[4]. A multicentered prospective study further reinforces that neonatal hypoglycemia is a frequent metabolic disorder associated with increased morbidity and mortality, underscoring the critical need to identify its predictors and intervene early in hospitalized neonates .

While the other interventions may be relevant in specific contexts, they do not address the most immediate, life-threatening physiological risk for a generic SGA newborn upon admission.

• Option 1 (Prophylactic antibiotics): SGA is not an independent indication for prophylactic antibiotic administration. Antibiotics are initiated based on maternal risk factors for sepsis (e.g., chorioamnionitis, GBS positivity) or clinical signs of infection in the newborn, not birth weight classification alone.


• Option 2 (Supine positioning): The "Back to Sleep" campaign recommends supine positioning for all healthy newborns to prevent sudden infant death syndrome (SIDS). However, positioning is a safety intervention, not one that addresses the acute metabolic instability inherent to SGA status. It does not take priority over preventing potentially brain-damaging hypoglycemia.


• Option 3 (Phototherapy): Phototherapy is a treatment for established pathological hyperbilirubinemia. While SGA infants with polycythemia may be at higher risk for jaundice, phototherapy is not a prophylactic measure initiated solely based on SGA classification. It is a response to a specific clinical finding (elevated bilirubin levels), making glucose stabilization the more immediate and universal priority.